JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M110687200 on January 30, 2002

J. Biol. Chem., Vol. 277, Issue 16, 14146-14152, April 19, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/16/14146    most recent
M110687200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mildner, M.
Right arrow Articles by Tschachler, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mildner, M.
Right arrow Articles by Tschachler, E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Hepatocyte Growth Factor/Scatter Factor Inhibits UVB-induced Apoptosis of Human Keratinocytes but Not of Keratinocyte-derived Cell Lines via the Phosphatidylinositol 3-Kinase/AKT Pathway*

Michael MildnerDagger , Leopold EckhartDagger , Barbara LengauerDagger , and Erwin TschachlerDagger §

From the Dagger  Division of Immunology, Allergy and Infectious Diseases, Department of Dermatology, Vienna Medical School, Währinger Gürtel 18-20, A-1090 Vienna, Austria and the § Centre de Recherches et d'Investigations Epidermiques et Sensorielles, 29521 Neuilly Seine, France

Received for publication, November 7, 2001, and in revised form, December 26, 2001

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Acute irrepairable UV-induced DNA damage leads to apoptosis of epidermal keratinocytes (KC) and the formation of sunburn cells, whereas less severely damaged cells survive but harbor the potential of tumor formation. Here we report that hepatocyte growth factor/scatter factor (HGF/SF) prevents UVB-induced apoptosis in primary KC cultured in vitro. When we analyzed the signaling pathways initiated by the HGF/SF receptor c-met, we found that the phosphatidylinositol (PI) 3-kinase and its downstream-element AKT and the mitogen-activated protein (MAP) kinase were activated. Inhibition of PI 3-kinase led to a complete abrogation of the anti-apoptotic effect of HGF/SF, whereas blockade of the MAP kinase pathway had no effect. In contrast to the observation with primary KC, HGF/SF could not enhance survival after UVB irradiation of HaCaT and A431 cell lines, despite the fact that in these cells the PI 3-kinase and MAP kinase pathways were also activated by HGF/SF. Cell cycle analysis of KC revealed a G2/M arrest after UVB irradiation and a complete loss of proliferating cells. Because HGF/SF in the skin is produced by dermal fibroblasts, our findings suggest that the HGF/SF-mediated rescue of KC from apoptosis represents an important paracrine loop by which UVB-damaged KC can be kept alive to maintain the epidermal barrier function but cannot further proliferate, thereby preventing the induction of epithelial skin tumors.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

HGF/SF1 derived from mesenchymal cells is a multifunctional cytokine that has been shown to have a variety of effects on cells of different origin. It was first identified as a potent mitogen for hepatocytes (1, 2), and more recently it was shown to promote cell motility and proliferation of KC, melanocytes, and kidney epithelial cells (for review see Ref. 3). Furthermore, HGF/SF is able to induce scattering of cells (4) and their invasion into extracellular matrix (5), thereby promoting tumor metastasis (6, 7). Recently HGF/SF has been shown to promote or inhibit apoptosis depending on the cell type. For example, in the renal epithelial cell line HKC, HGF/SF acts as a survival factor after serum withdrawal (8, 9); it inhibits hepatocyte apoptosis in Fas-induced fulminant hepatic failure in a mouse model (10) but is able to induce apoptosis of sarcoma 180 cells (11).

The receptor for HGF/SF is a heterodimeric tyrosine kinase encoded by the c-met proto-oncogene, consisting of a 50-kDa extracellular alpha -subunit and a 145-kDa transmembrane beta -subunit (12). c-met signaling is mediated by autophosphorylation on Tyr1334 and Tyr1335 of the beta -subunit, which leads to a strong up-regulation of its kinase activity (13). As a result, a multifunctional docking site for adaptor molecules on the C-terminal tail of the beta -subunit becomes phosphorylated at the tyrosine residues on position Tyr1349 and Tyr1356. Their phosphorylation leads to interaction of c-met with several cytoplasmic signal transducers. This occurs either directly, such as with the PI 3-kinase, or indirectly via molecular adapters such as Grb2 (14), Shc (15), or Gab1 (7), activating the MAP kinase (16) and the STAT-3 pathways (17). The MAP kinase pathway has been shown to be responsible for cell growth (14), whereas the phosphorylation of STAT-3 and the resulting nuclear signaling is required for triggering differentiation for branching morphogenesis (17). The PI 3-kinase pathway is responsible for cell scattering by inducing the loss of intercellular junctions and cell migration (18). This pathway has recently been shown to also be involved in the anti-apoptotic activity of HGF/SF in renal tubular epithelial cell line (19), in hepatocytes (20), and in NIH 3T3 fibroblasts (21).

For the skin, UV irradiation is the most important DNA damaging stimulus and represents the major risk factor for the development of epithelial skin tumors (22). Whereas mild UV-induced damage induces DNA repair, severe UV exposure leads to irrepairable DNA damage resulting in KC apoptosis and the formation of sunburn cells (23, 24). It has been suggested that this UV-induced apoptosis contributes to the homeostasis of the epidermis and helps to prevent skin cancer by preferentially eliminating DNA-damaged KC (25). However, because a substantial loss of keratinocytes would result in a life-threatening damage of the skin barrier function, we are interested in mechanisms that counteract UV-induced KC apoptosis. In the present study we demonstrate that HGF/SF inhibits UV-induced apoptosis of KC and arrests them irreversibly in the G2/M phase of the cell cycle.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Cell Culture-- KC derived from normal neonatal foreskin of single donors were purchased from Clonetics (San Diego, CA). They were cultured at low calcium concentrations in KC growth medium (Clonetics) provided by the supplier (0.15 mM). The epidermoid cell line A431 and the KC-derived cell line HaCaT (26) were cultured in either KC growth medium or in RPMI 1640 (Invitrogen) supplemented with 10% fetal bovine serum (PAA, Linz, Austria), 25 mM L-glutamine (Invitrogen), and 1% penicillin/streptomycin (Invitrogen). 12-15 h before irradiation, KC were changed to KC basic medium (KBM; Clonetics) without growth factors. The cell lines were either changed to serum-free conditions in RPMI 1640 or to KBM. After irradiation, the culture was continued in KBM or RPMI 1640, respectively, with or without HGF/SF (20 ng/ml; R & D Systems, Minneapolis, MN). All tissue culture was performed at 37 °C in 5% CO2 and 95% air.

UV Irradiation-- For irradiation experiments 1 × 105 cells/well were seeded in 12-well plates (Costar, Cambridge, MA) and cultured overnight in KBM or RPMI 1640 without serum. Prior to irradiation, the cells were washed twice with phosphate-buffered saline, pH 7.4 (Invitrogen). UVB irradiation was carried out as described previously (27). As a light source a Mutzhas Supersun 5000-type solar simulator (Mutzhas, Munich, Germany) filtered for the emission of UVB (290-330 nm) was used. Energy output was monitored with a IL-1700 radiometer (International Light, Newburyport, MA). Energy output was 0.7 mW/cm2 at a tube to target distance of 30 cm. The cells were irradiated with 8, 16, 24, and 32 mJ/cm2 of UVB under a thin layer of phosphate-buffered saline at 25 °C. For some experiments the cells were also irradiated at 4 °C. For each experiment, control cells were treated identically, except for the exposure to UV light. Immediately after irradiation phosphate-buffered saline was removed, and prewarmed basic medium with or without HGF/SF was added. The cells were followed up to 5 days after irradiation.

Apoptosis Detection Assays-- To quantify the extent of cell death, nonadherent cells were washed off with phosphate-buffered saline. After fixation in methanol, the remaining adherent cells were stained with methylene blue (Sigma; 0.5% in methanol). Excess methylene blue was washed out with distilled water, and the culture wells were evaluated with an inverted microscope for the presence of adherent cells. The activity of caspase-3 in cell lysates was determined according to a published protocol (28), using the synthetic caspase-3 substrate Ac-DEVD-pNA (Calbiochem, La Jolla, CA). Color development was measured on an enzyme-linked immunosorbent assay reader at 405 nm. Nucleosome release into the cytoplasm was measured with an enzyme-linked immunosorbent assay according to the manufacturer's instructions (Roche Molecular Biochemicals).

Western Blot Analysis-- Western blot analysis was performed as described previously (29). Briefly, 107 cells were lysed in 1% Nonidet P-40 lysis buffer. After quantification with the micro-beta protein quantification kit (Pierce), the proteins were size fractionated by PAGE through an 8-18% gradient gel (Amersham BioSciences) and transferred onto nitrocellulose membranes (Schleicher & Schüll). Immunodetection was performed with an anti-phospho-AKT (1 µg/ml, New England Biolabs, Beverly, MA), anti-phospho-MAP kinase (1 µg/ml, Upstate Biotechnologies, Lake Placid, NY), and anti-c-met (1 µg/ml, Upstate Biotechnologies) monoclonal antibody, followed by a horseradish peroxidase-conjugated sheep anti-mouse IgG antiserum (1:10000; Amersham BioSciences). In parallel an identical blot was reacted to an irrelevant isotype-matched monoclonal antibody as negative control. The reaction products were detected by chemiluminescence with the ECL kit (Amersham BioSciences) according to the manufacturer's instructions. Blots were quantified using the Gel-Pro Analyzer 3.1 software.

Inhibition of Kinases-- For the inhibition of the PI 3-kinase and MAP kinase, KC were treated with the PI 3-kinase inhibitors wortmannin (1 µM; Sigma) or LY294002 (5 µM; Sigma) or with the MAP kinase inhibitor PD98059 (5 µM; Biomol, Vienna, Austria) for 1 h prior to exposure to UVB. After UVB irradiation the prewarmed KBM was also supplemented with the kinase inhibitors. 15 h after irradiation, the cells were assayed for apoptotic cell death by light microscopy, nucleosome release, and caspase-3 activation.

Cell Cycle Analysis-- 24 and 48 h after UVB irradiation cells were incubated with bromodeoxyuridine, and 2 h later cell cycle analysis was performed using the BrdU-Flow kit (Becton Dickinson, Vienna, Austria) according to the manufacturer's instructions.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

UV-induced Apoptosis of KC, but Not of A431 and HaCaT Cells, Is Inhibited by HGF/SF-- As shown in Fig. 1 irradiation with 16 mJ/cm2 induced cell death of KC (Fig. 1b) and the KC-derived cell lines A431 (Fig. 1e) and HaCaT (Fig. 1h). The addition of 20 ng/ml HGF/SF inhibited cell death and detachment of KC (Fig. 1c), whereas no inhibition was seen with A431 (Fig. 1f) and HaCaT (Fig. 1i) cells. The induction of caspase-3-activity (Fig. 2A) and the release of nucleosomes into the cytoplasm (Fig. 2C) confirmed that both KC and KC-derived cell lines died by apoptosis. The addition of HGF/SF to UV-irradiated KC prevented nucleosome release (Fig. 2D) and caspase activation (Fig. 2B) but had no such effect on A431 (Fig. 2, B and D) and HaCaT cells (Fig. 2, B and D). The fact that HGF/SF-treated KC remained viable after UV exposure throughout the observation period of up to 5 days proved that HGF/SF was indeed able to block rather than delay apoptosis (data not shown). Inhibition of UVB-induced apoptosis in KC could be observed at HGF/SF doses as low as 1 ng/ml (Fig. 3A) and also occurred when the factor was added 2 h after exposure to UVB. No inhibition of apoptosis was observed when HGF/SF was added 4 h after UV exposure (Fig. 3B).


View larger version (100K):
[in this window]
[in a new window]
 
Fig. 1.   HGF/SF inhibits UVB-induced cell death in KC but not in KC-derived cell lines. To demonstrate the extent of apoptosis, dead cells were washed off, and surviving cells were fixed and stained with methylene blue solution 15 h after UVB irradiation. Non-irradiated cells showed no morphological changes (a, d, and g). Strong induction of cell death could be observed in KC (b), A431 (e), and HaCaT (h) after exposure to 16 mJ/cm2 UVB. The addition of 20 ng/ml HGF/SF to KC (c) completely blocked UVB-induced cell death, whereas it showed no effect on the prevention of apoptosis in A431 (f) and HaCaT cells (i). One representative experiment of five is shown.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 2.   HGF/SF inhibits UVB-induced histone release and the activation of caspase-3 in KC but not in KC-derived cell lines. At different time points after UVB irradiation, the cell lysates were tested for caspase-3 activity (A and B) and histone release (C and D). Exposure to UVB led to caspase-3 activation (A) and nucleosome release (C) in both KC and KC-derived cell lines. The addition of HGF/SF blocked this effect in KC but not in A431 and HaCaT cells (B and D). One representative experiment of five is shown. The error bars represent one standard deviation calculated from three replicates for each set of values.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 3.   Dose- and time-dependent inhibition of UVB-induced apoptosis in KC. Different concentrations of HGF/SF were added after UVB irradiation of KC. Nucleosome release of KC is depicted in A. As shown in B, the anti-apoptotic effect of HGF/SF was observed even when it was added 2 h after UV irradiation. 4 h after exposure to UVB, the protective effect of HGF/SF was lost. One representative experiment of two is shown. The error bars represent one standard deviation calculated from three replicates for each set of values.

The Anti-apoptotic Effect of HGF/SF Is Mediated by Signaling via PI 3-Kinase-- Three different signaling pathways, i.e. the PI 3-kinase, the MAP kinase, and the STAT-3 pathways are involved in HGF/SF signaling. Blockade of the PI 3-kinase pathway by wortmannin (Fig. 4, c and d) or LY294002 (Fig. 4, e and f) completely abolished the anti-apoptotic effect of HGF/SF after UVB irradiation (Fig. 4, d and f). By contrast, the MAP kinase inhibitor PD98059 had no effect on the prevention of UVB-induced cell death (Fig. 4, g and h). As expected from these results, wortmannin and LY294002 blocked the release of nucleosomes into the cytoplasm (Fig. 5A) and the activation of caspase-3 (Fig. 5B), whereas addition of PD98059 had no such effect. Thus HGF/SF transduces the anti-apoptotic signal via the PI 3-kinase pathway.


View larger version (124K):
[in this window]
[in a new window]
 
Fig. 4.   HGF/SF prevents KC apoptosis via the PI 3-kinase pathway. The addition of the PI 3-kinase inhibitors wortmannin (c and d) or LY294002 (e and f) abrogated the anti-apoptotic effect of HGF/SF on KC (d and f). The addition of the MAP kinase inhibitor PD98059 (g and h) did not neutralize the anti-apoptotic effect of HGF/SF. a and b depict UV-irradiated KC without and with addition of HGF/SF, respectively. One representative experiment of two is shown.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 5.   The inhibition of nucleosome release and caspase-3 activation by HGF/SF after UVB irradiation is blocked by PI 3-kinase inhibitors. The addition of 20 ng/ml HGF/SF blocked KC apoptosis after UV treatment. Blockade of the PI 3-kinase pathway by wortmannin (Wort) and LY294002 (LY) abolished the anti-apoptotic effect of HGF/SF on KC and led to the release of nucleosomes into the cytoplasm (A) and the activation of capase-3 (B). Blocking the MAP kinase pathway by PD98059 (PD) did not alter the protective effect of HGF/SF for KC after UVB irradiation. None of these three substances alone had an effect on the cell viability. One representative experiment of two is shown. The error bars represent one standard deviation calculated from three replicates for each set of values.

c-met Is Functionally Active in Both KC and KC-derived Cell Lines-- Because A431 and HaCaT cells were not protected from UVB-induced apoptosis by HGF/SF, we asked whether these cell lines express the receptor for HGF/SF, c-met. When we analyzed the expression of c-met in KC and A431 and HaCaT cells, proteins of identical sizes, i.e. 190 and 145 kDa under nonreducing conditions and 145 and 95 kDa under reducing conditions, were detected in primary KC and both cell lines (Fig. 6). Sequence analysis of the c-met receptor revealed no differences in the sequence of the multifunctional docking site (YV(H/N)V16) between KC and KC cell lines (data not shown). To test whether c-met was functional in the KC-derived cell lines, we analyzed the phosphorylation status of AKT and MAP kinase in these cells and KC after HGF/SF stimulation. We found a strong induction of phosphorylation of both kinases in HaCaT (Fig. 7, bottom left panel) and A431 (Fig. 7, bottom right panel) cells as well as in KC (Fig. 7, top panel). The maximal induction of AKT phosphorylation was 7.4-fold in HaCaT, 4.4-fold in A431 cells, and 51-fold in KC. For MAP kinase phosphorylation, the induction was 29.8-fold in HaCaT, 10.3-fold in A431 cells, and 19-fold in KC. When the maximal levels of induction were compared between the tree cell types, we found that AKT phosphorylation was 2 and 13 times stronger in KC than in HaCaT and A431, respectively. For MAP kinase phosphorylation the maximal induction was 0.8 and 4.6 times stronger in KC than in HaCaT and A431, respectively. Thus activation of c-met by HGF/SF leads to phosphorylation of its target kinases in all three cell types, suggesting that the signaling pathway is intact in both KC and KC-derived cell lines. However, the fact that the maximal levels of induction of phosphorylation were considerably stronger in KC (51-fold) as compared with both cell lines (7.4- and 4.4-fold) indicates differences in signal transduction between the different cell types.


View larger version (52K):
[in this window]
[in a new window]
 
Fig. 6.   KC and KC-derived cell lines express c-met. c-met expression was studied by Western blot analysis under nonreducing (lanes 1-3) and reducing conditions (lanes 4-6). No differences in the c-met expression between KC (lanes 1 and 4) and A431 (lanes 2 and 5) and HaCaT cells (lanes 3 and 6) was observed.


View larger version (42K):
[in this window]
[in a new window]
 
Fig. 7.   MAP kinase and AKT becomes phosphorylated in KC and KC-derived cell lines. The addition of HGF/SF led to rapid phosphorylation of AKT and MAP kinase (MAPK) in KC (A), HaCaT (B), and A431 (C) cells. The induction of phosphorylation was seen already after 2 min and remained up to 1 h. One representative experiment of two is shown.

Keratinocytes Protected by HGF/SF against UV-induced Apoptosis Enter Irreversible Cell Cycle Arrest-- When after irradiation KC were cultured either in the absence or presence of HGF/SF, we observed that in both cases the surviving cells did not proliferate but remained viable for at least up to 5 days. By cell cycle analysis after 24 h, we found a normal distribution of the different stages of the cell cycle in nonirradiated untreated cells (Fig. 8A) as well as in non-irradiated HGF/SF-treated cells (Fig. 8B). Irradiation of cells with UVB (16 mJ/cm2) led to a complete loss of the S phase in the surviving cells, with a simultaneous increase in the number of cells in the G2/M phase (Fig. 8C). The addition of HGF/SF to UVB-irradiated KC inhibited apoptosis but did not lead to entry into S phase (Fig. 8D). Virtually the same results were obtained when cells were analyzed after 48 h (data not shown). When analyzing untreated A431 cells, we found that as compared with KC, a higher percentage of cells were in the S phase, which corresponds to their higher proliferative capacity (Fig. 8A). The addition of HGF/SF did not change the distribution of the different stages of cell cycle (Fig. 8B). In contrast to KC, irradiation of A431 cells with UVB did not lead to cell cycle arrest in the G2/M phase. Although most of the cells died after exposure to UVB, the surviving cells were distributed all over the different stages of the cell cycle (Fig. 8C). The addition of HGF/SF neither had an impact on A431 survival (see above) nor influenced the cell cycle distribution of surviving cells (Fig. 8D).


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 8.   Cell cycle arrest of KC after UVB irradiation with or without HGF/SF. Untreated KC and A431 cells show a normal distribution of the different stages of the cell cycle (A) that is not altered by addition of HGF/SF (B). UVB irradiation led to cell cycle arrest and a loss of the proliferative capacity in KC but not in A431 cells (C). In contrast to A431 cells, the addition of HGF/SF led to the survival of irradiated KC but showed a loss of cells in the S phase and an increase in the G2/M phase (D) comparable with the UV-only treated cells (C).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Apoptosis is the consequence of a genetically determined cell death program that can be initiated by a number of stimuli such as growth factor withdrawal, signaling through apoptotic receptors, or cell damaging stress (for review see Ref. 30). Induction of apoptosis by DNA damaging agents plays a central role in the elimination of genetically altered cells, contributing to the inhibition of tumor development (23). In the skin UV irradiation is the most relevant DNA damaging stimulus and represents the major risk factor for the development of epithelial skin tumors (22). Whereas mild UV-induced damage induces DNA repair, severe UV exposure leads to irrepairable DNA damage resulting in KC apoptosis and the formation of sunburn cells (23, 24).

In the present study, we demonstrate that UVB-induced apoptosis of human KC in primary culture is completely inhibited by HGF/SF in the absence of other growth factors. In contrast to primary KC, identical treatment had no effect on the survival of the two autonomously growing KC-derived cell lines HaCaT and A431. In our experiments, we identified the PI 3-kinase/AKT pathway as the one responsible for conferring UV resistance to KC, i.e. both wortmannin and LY294002 completely abolished the anti-apoptotic effect of HGF/SF. This part of our data complements recent data by others who showed that HGF/SF confers protection against apoptosis of a renal epithelial cell line (19), of NIH 3T3 cells (21), and of hepatocytes (20) via the PI 3-kinase pathway. Blockade of the MAP kinase pathway by PD98059 had no effect on KC survival, which was surprising because activation of this pathway by insulin-like growth factor-1 has been shown to protect KC against UV-induced apoptosis (31).

Our finding that HGF/SF, although protecting KC, could not prevent apoptosis of A431 and HaCaT cells was unexpected because Tang et al. (32) have recently reported that activating the PI 3-kinase pathway via beta 4 integrin protects A431 cells from apoptosis. Our data exclude the possibility that the lack of protection was due to an impaired PI 3-kinase signaling, because we demonstrated that like in primary KC, activation via c-met led to AKT phosphorylation in A431 and HaCaT cells. In the light of the data of Tang et al., namely that the PI 3-kinase pathway is functional in prevention of apoptosis in A431 cells, our results suggest that in these cells, either pathways downstream of AKT cannot be activated efficiently via c-met or its activation does not lead to protection from UV-mediated apoptosis. As to the first possibility, although we could demonstrate that the MAP kinase signaling and although the activation of AKT via c-met is intact in all three cell types analyzed, we cannot rule out at present that the signaling downstream of AKT is disturbed. Phosphorylation of AKT leads to the activation and inactivation of several factors that have been shown to be involved in the induction or prevention of apoptosis. For example GSK-3, a ubiquitously expressed serine/threonine protein kinase (33); FKHR, a member of the Forkhead family of transcription factors (33, 34); and Bad, an apoptotic member of the Bcl-2 family (35), are molecules that become phosphorylated by activated AKT. If any or a combination of these pathways is disturbed in the KC-derived cell lines, then no signal transduction would take place despite the presence of a functional receptor. Our finding that the amount of phosphorylated AKT was considerably lower in the cell lines than in KC suggests that in the cell lines activation of the downstream pathway might be less effective than in KC. As to the second possibility, it is tempting to speculate that different triggers of apoptosis, i.e. UV-induced DNA damage, as opposed to lack of membrane signaling via integrins might account for differing protection by HGF/SF in these cells. However, further studies will be necessary to test this hypothesis.

Furthermore, with regard to the observed differences between primary cells and autonomously growing cell lines, different pathways of cell death signaling might be the cause for the distinct anti-apoptotic effects of HGF/SF. Both HaCaT and A431 cells contain mutations in the p53 gene, which plays a central role in UV-induced apoptosis (36, 37). Therefore, it is highly probable that UV-induced DNA damage leads to apoptosis via p53-dependent and -independent pathways in primary cells and cell lines, respectively. That indeed DNA damage and not UV-induced membrane effects such as the clustering of CD95 (38) was the primary responsible apoptotic trigger in our experiments is strongly suggested by our finding that UV-induced apoptosis occurred after irradiation of cells at 25 °C as well as at 4 °C (data not shown). Irradiation at 4 °C blocks UVB-induced CD95 clustering but has no effect on UV-mediated DNA damage (38).

As to the biological implications of our findings, it is important to keep in mind that in the skin dermal fibroblasts are a powerful source for HGF/SF (39). HGF/SF production is induced in these cells after stimulation with phorbol ester (40), interleukin-1 (41), and tumor necrosis factor-alpha (42). Because production the latter two factors by KC is induced by UV irradiation (43, 44), their secretion would result in the triggering of HGF/SF production by fibroblasts and the establishment of a paracrine loop between epidermal and dermal symbionts, allowing the survival of KC after UV injury.

UV-induced apoptosis is thought to contribute to skin homeostasis by preferentially eliminating KC with irreparable DNA damage, i.e. potentially precancerous cells, and has been referred to as "cellular proofreading" (25), in analogy to proofreading and excision of incorrect base pairs during DNA synthesis. Indeed, mice that are deficient in p53 and therefore have a decreased capacity of DNA repair show a decreased tendency of sunburn cell formation and are more susceptible to the development of UV-induced tumors (45). For this reason UV-induced KC apoptosis by itself cannot merely be regarded as a harmful event but is thought to help reduce or prevent skin carcinogenesis (25, 45). Protection of KC by the inhibition of apoptosis might therefore be a double-edged sword potentially favoring the survival of cells with DNA damage. A possibility to circumvent such a harmful scenario would be that HGF/SF-protected KC enter a postmitotic state. We could show in our experiments that KC protected by HGF/SF do not further proliferate in vitro. If this holds true in vivo, these cells would be removed from the replicating population, thereby reducing the risk of transformation while keeping them alive and thus maintaining the integrity of the skin barrier. With regard to the differences observed between cells in primary culture and cell lines bearing p53 mutations, it is tempting to speculate that HGF/SF might preferentially protect nontransformed KC in vivo while leaving transformed cells to be eliminated by UV irradiation, implying a possible beneficial effect of strong UV irradiation in the removal of precancerous epithelial skin lesions.

    ACKNOWLEDGEMENT

We thank H. Rossiter for critical reading of the manuscript.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Dept. of Dermatology, University of Vienna Medical School, Währinger Gürtel 18-20, A-1090 Vienna, Austria. Tel.: 43-1-4081271; Fax: 43-1-4034922; E-mail: Erwin.Tschachler@akh-wien.ac.at.

Published, JBC Papers in Press, January 30, 2002, DOI 10.1074/jbc.M110687200

    ABBREVIATIONS

The abbreviations used are: HGF/SF, hepatocyte growth factor/scatter factor; KC, normal epidermal keratinocyte(s); PI, phosphatidylinositol; AKT, protein kinase B; MAP, mitogen-activated protein; KBM, KC basic medium.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Montesano, R., Matsumoto, K., Nakamura, T., and Orci, L. (1991) Cell 67, 901-908[CrossRef][Medline] [Order article via Infotrieve]
2. Nakamura, T., Nishizawa, T., Hagiya, M., Seki, T., Shimonishi, M., Sugimura, A., Tashiro, K., and Shimizu, S. (1989) Nature 342, 440-444[CrossRef][Medline] [Order article via Infotrieve]
3. Rubin, J. S., Bottaro, D. P., and Aaronson, S. A. (1993) Biochim. Biophys. Acta 1155, 357-371[Medline] [Order article via Infotrieve]
4. Stoker, M., Gherardi, E., Perryman, M., and Gray, J. (1987) Nature 327, 239-242[CrossRef][Medline] [Order article via Infotrieve]
5. Giordano, S., Zhen, Z., Medico, E., Gaudino, G., Galimi, F., and Comoglio, P. M. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 649-653[Abstract/Free Full Text]
6. Jeffers, M., Rong, S., and Vande, W. G. (1996) Mol. Cell. Biol. 16, 1115-1125[Abstract]
7. Weidner, K. M., Di, C. S., Sachs, M., Brinkmann, V., Behrens, J., and Birchmeier, W. (1996) Nature 384, 173-176[CrossRef][Medline] [Order article via Infotrieve]
8. Liu, Y., Sun, A. M., and Dworkin, L. D. (1998) Biochem. Biophys. Res. Commun. 246, 821-826[CrossRef][Medline] [Order article via Infotrieve]
9. Yo, Y., Morishita, R., Nakamura, S., Tomita, N., Yamamoto, K., Moriguchi, A., Matsumoto, K., Nakamura, T., Higaki, J., and Ogihara, T. (1998) Kidney. Int. 54, 1128-1138[CrossRef][Medline] [Order article via Infotrieve]
10. Kosai, K., Matsumoto, K., Nagata, S., Tsujimoto, Y., and Nakamura, T. (1998) Biochem. Biophys. Res. Commun. 244, 683-690[CrossRef][Medline] [Order article via Infotrieve]
11. Arakaki, N., Kazi, J. A., Kazihara, T., Ohnishi, T., and Daikuhara, Y. (1998) Biochem. Biophys. Res. Commun. 245, 211-215[CrossRef][Medline] [Order article via Infotrieve]
12. Bottaro, D. P., Rubin, J. S., Faletto, D. L., Chan, A. M., Kmiecik, T. E., Vande, W. G., and Aaronson, S. A. (1991) Science 251, 802-804[Abstract/Free Full Text]
13. Longati, P., Bardelli, A., Ponzetto, C., Naldini, L., and Comoglio, P. M. (1994) Oncogene 9, 49-57[Medline] [Order article via Infotrieve]
14. Ponzetto, C., Zhen, Z., Audero, E., Maina, F., Bardelli, A., Basile, M. L., Giordano, S., Narsimhan, R., and Comoglio, P. (1996) J. Biol. Chem. 271, 14119-14123[Abstract/Free Full Text]
15. Pelicci, G., Giordano, S., Zhen, Z., Salcini, A. E., Lanfrancone, L., Bardelli, A., Panayotou, G., Waterfield, M. D., Ponzetto, C., Pelicci, P. G., and Comoglio, P. M. (1995) Oncogene 10, 1631-1638[Medline] [Order article via Infotrieve]
16. Ponzetto, C., Bardelli, A., Zhen, Z., Maina, F., Dalla, Z. P., Giordano, S., Graziani, A., Panayotou, G., and Comoglio, P. M. (1994) Cell 77, 261-271[CrossRef][Medline] [Order article via Infotrieve]
17. Boccaccio, C., Ando, M., Tamagnone, L., Bardelli, A., Michieli, P., Battistini, C., and Comoglio, P. M. (1998) Nature 391, 285-288[CrossRef][Medline] [Order article via Infotrieve]
18. Royal, I., and Park, M. (1995) J. Biol. Chem. 270, 27780-27787[Abstract/Free Full Text]
19. Liu, Y. H. (1999) Am. J. Physiol. 277, F624-F633[Medline] [Order article via Infotrieve]
20. Webster, C. R., and Anwer, M. S. (2001) Hepatology 33, 608-615[CrossRef][Medline] [Order article via Infotrieve]
21. Xiao, G. H., Jeffers, M., Bellacosa, A., Mitsuuchi, Y., Vande Woude, G. F., and Testa, J. R. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 247-252[Abstract/Free Full Text]
22. Kraemer, K. H. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 11-14[Free Full Text]
23. Brash, D. E., Ziegler, A., Jonason, A. S., Simon, J. A., Kunala, S., and Leffell, D. J. (1996) J. Investig. Dermatol. Symp. Proc. 1, 136-142[Medline] [Order article via Infotrieve]
24. Schwarz, A., Bhardwaj, R., Aragane, Y., Mahnke, K., Riemann, H., Metze, D., Luger, T. A., and Schwarz, T. (1995) J. Invest. Dermatol. 104, 922-927[CrossRef][Medline] [Order article via Infotrieve]
25. Brash, D. E. (1996) Nat. Med. 2, 525-526[CrossRef][Medline] [Order article via Infotrieve]
26. Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A., and Fusenig, N. E. (1988) J. Cell Biol. 106, 761-771[Abstract/Free Full Text]
27. Mildner, M., Weninger, W., Trautinger, F., Ban, J., and Tschachler, E. (1999) Photochem. Photobiol. 70, 674-679[CrossRef][Medline] [Order article via Infotrieve]
28. Wright, S. C., Schellenberger, U., Wang, H., Kinder, D. H., Talhouk, J. W., and Larrick, J. W. (1997) J. Exp. Med. 186, 1107-1117[Abstract/Free Full Text]
29. Plettenberg, A., Ballaun, C., Pammer, J., Mildner, M., Strunk, D., Weninger, W., and Tschachler, E. (1995) Am. J. Pathol. 146, 651-659[Abstract]
30. Rich, T., Watson, C. J., and Wyllie, A. (1999) Nat. Cell Biol. 1, 69-71[CrossRef][Medline] [Order article via Infotrieve]
31. Kuhn, C., Hurwitz, S. A., Kumar, M. G., Cotton, J., and Spandau, D. F. (1999) Int. J. Cancer. 80, 431-438[CrossRef][Medline] [Order article via Infotrieve]
32. Tang, K. Q., Nie, D. T., Cai, Y. L., and Honn, K. V. (1999) Biochem. Biophys. Res. Commun. 264, 127-132[CrossRef][Medline] [Order article via Infotrieve]
33. Pap, M., and Cooper, G. M. (1998) J. Biol. Chem. 273, 19929-19932[Abstract/Free Full Text]
34. Rena, G., Guo, S., Cichy, S. C., Unterman, T. G., and Cohen, P. (1999) J. Biol. Chem. 274, 17179-17183[Abstract/Free Full Text]
35. Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., and Greenberg, M. E. (1997) Cell 91, 231-241[CrossRef][Medline] [Order article via Infotrieve]
36. Henseleit, U., Zhang, J., Wanner, R., Haase, I., Kolde, G., and Rosenbach, T. (1997) J. Invest. Dermatol. 109, 722-727[CrossRef][Medline] [Order article via Infotrieve]
37. Reiss, M., Brash, D. E., Munoz, A. T., Simon, J. A., Ziegler, A., Vellucci, V. F., and Zhou, Z. L. (1992) Oncol. Res. 4, 349-357[Medline] [Order article via Infotrieve]
38. Aragane, Y., Kulms, D., Metze, D., Wilkes, G., Poppelmann, B., Luger, T. A., and Schwarz, T. (1998) J. Cell Biol. 140, 171-182[Abstract/Free Full Text]
39. Stoker, M., and Perryman, M. (1985) J. Cell Sci. 77, 209-223[Abstract]
40. Gohda, E., Kataoka, H., Tsubouchi, H., Daikilara, Y., and Yamamoto, I. (1992) FEBS Lett. 301, 107-110[CrossRef][Medline] [Order article via Infotrieve]
41. Matsumoto, K., Okazaki, H., and Nakamura, T. (1992) Biochem. Biophys. Res. Commun. 188, 235-243[CrossRef][Medline] [Order article via Infotrieve]
42. Tamura, M., Arakaki, N., Tsubouchi, H., Takada, H., and Daikuhara, Y. (1993) J. Biol. Chem. 268, 8140-8145[Abstract/Free Full Text]
43. Kupper, T. S., Chua, A. O., Flood, P., McGuire, J., and Gubler, U. (1987) J. Clin. Invest. 80, 430-436[Medline] [Order article via Infotrieve]
44. Kock, A., Schwarz, T., Kirnbauer, R., Urbanski, A., Perry, P., Ansel, J. C., and Luger, T. A. (1990) J. Exp. Med. 172, 1609-1614[Abstract/Free Full Text]
45. Hill, L. L., Ouhtit, A., Loughlin, S. M., Kripke, M. L., Ananthaswamy, H. N., and Owen, S. L. (1999) Science 285, 898-900[Abstract/Free Full Text]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
A. L. Kadekaro, R. Kavanagh, H. Kanto, S. Terzieva, J. Hauser, N. Kobayashi, S. Schwemberger, J. Cornelius, G. Babcock, H. G. Shertzer, et al.
{alpha}-Melanocortin and Endothelin-1 Activate Antiapoptotic Pathways and Reduce DNA Damage in Human Melanocytes
Cancer Res., May 15, 2005; 65(10): 4292 - 4299.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Bohm, I. Wolff, T. E. Scholzen, S. J. Robinson, E. Healy, T. A. Luger, T. Schwarz, and A. Schwarz
{alpha}-Melanocyte-stimulating Hormone Protects from Ultraviolet Radiation-induced Apoptosis and DNA Damage
J. Biol. Chem., February 18, 2005; 280(7): 5795 - 5802.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. He, Y.-Y. Cho, W.-Y. Ma, H. S. Choi, A. M. Bode, and Z. Dong
Regulation of Ultraviolet B-induced Phosphorylation of Histone H3 at Serine 10 by Fyn Kinase
J. Biol. Chem., January 28, 2005; 280(4): 2446 - 2454.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. Kakazu, G. Chandrasekher, and H. E. P. Bazan
HGF Protects Corneal Epithelial Cells from Apoptosis by the PI-3K/Akt-1/Bad- but Not the ERK1/2-Mediated Signaling Pathway
Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3485 - 3492.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Rasola, S. Anguissola, N. Ferrero, D. Gramaglia, A. Maffe, P. Maggiora, P. M. Comoglio, and M. F. Di Renzo
Hepatocyte Growth Factor Sensitizes Human Ovarian Carcinoma Cell Lines to Paclitaxel and Cisplatin
Cancer Res., March 1, 2004; 64(5): 1744 - 1750.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Y. Sun, J. Yuan, H. Liu, Z. Shi, K. Baker, K. Vuori, J. Wu, and G.-S. Feng
Role of Gab1 in UV-Induced c-Jun NH2-Terminal Kinase Activation and Cell Apoptosis
Mol. Cell. Biol., February 15, 2004; 24(4): 1531 - 1539.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. Zhang, J. Baffi, S. W. Cousins, and K. G. Csaky
Oxidant-induced cell death in retinal pigment epithelium cells mediated through the release of apoptosis-inducing factor
J. Cell Sci., May 15, 2003; 116(10): 1915 - 1923.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Garcia-Ocana, K. K. Takane, V. T. Reddy, J.-C. Lopez-Talavera, R. C. Vasavada, and A. F. Stewart
Adenovirus-mediated Hepatocyte Growth Factor Expression in Mouse Islets Improves Pancreatic Islet Transplant Performance and Reduces Beta Cell Death
J. Biol. Chem., January 3, 2003; 278(1): 343 - 351.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/16/14146    most recent
M110687200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar